首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression
【24h】

MiR-939 promotes the proliferation of human ovarian cancer cells by repressing APC2 expression

机译:MiR-939通过抑制APC2表达来促进人卵巢癌细胞的增殖

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Aberrant activation of the Wnt/beta-catenin signal pathway is frequently observed in various human cancers. Therefore, it was speculated that adenomatous polyposis coli 2 (APC2) could play important roles in activating the Wnt/b-catenin pathway. In this present study, miR-939 expression was markedly upregulated in ovarian cancer tissues and ovarian cancer cells. In functional assays, Overexpression of miR-939 promoted the proliferation and anchorage-independent growth of ovarian cancer cells, whereas inhibition of miR-939 inhibited this effect. Bioinformatics analysis further revealed APC2, a putative tumor suppressor as a potential target of miR-939. Result of luciferase reporter assays showed that miR-939 directly binds to the 30-untranslated region (30-UTR) of APC2 mRNA. Furthermore, we demonstrated that miR-939 could reduce the Wnt/b-catenin signal pathway by suppressing APC2 directly, resulting in increasing expression of CyclinD1, MYC and TCF. In functional assays, APC2-silenced in miR-939-in-transfected ES-2 cells have positive effect to promote cell proliferation, suggesting that direct APC2 downregulation is required for miR-939-induced ovarian cancer cell proliferation. In sum, our data provided compelling evidence that miR-939 functioned as a potential tumor promoter by regulating the Wnt/b-catenin signal pathway through direct suppression of APC2 expression and might sever as a potential therapeutic target for ovarian cancer patients. (C) 2015 Elsevier Masson SAS. All rights reserved.
机译:在各种人类癌症中经常观察到Wnt /β-catenin信号通路的异常激活。因此,推测腺瘤性息肉病大肠杆菌2(APC2)可能在激活Wnt / b-catenin途径中起重要作用。在本研究中,miR-939表达在卵巢癌组织和卵巢癌细胞中明显上调。在功能测定中,miR-939的过表达促进卵巢癌细胞的增殖和不依赖贴壁的生长,而对miR-939的抑制则抑制了这一作用。生物信息学分析进一步揭示了APC2,一种可能的肿瘤抑制物,可能是miR-939的潜在靶标。荧光素酶报告基因分析的结果表明,miR-939直接与APC2 mRNA的30个非翻译区(30-UTR)结合。此外,我们证明了miR-939可以通过直接抑制APC2来减少Wnt / b-catenin信号通路,从而导致CyclinD1,MYC和TCF的表达增加。在功能测定中,沉默于miR-939的转染ES-2细胞中的APC2具有促进细胞增殖的积极作用,这表明miR-939诱导的卵巢癌细胞增殖需要直接的APC2下调。总而言之,我们的数据提供了令人信服的证据,表明miR-939通过直接抑制APC2表达来调节Wnt / b-catenin信号通路,从而发挥了潜在的肿瘤启动子的作用,并且可能会成为卵巢癌患者的潜在治疗靶标。 (C)2015 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号